English
简体中文
Total: £ 56.28
Published Date: 2025-11-12 | Pages: 133 | Tables: 140 | Medical Care
The global Cold Pain Therapy OTC Products market is projected to grow from US$ 1388 million in 2024 to US$ 1944 million by 2031, at a CAGR of 5.0% (2025-2031), driven by critical product segments and diverse end‑use applications.
Cryotherapy means cold therapy. Cold therapy can be applied in different ways. That can include ice packs, coolant sprays, ice massage, whirlpools, and ice baths. When used to treat injuries at home, cold therapy refers to therapy with ice or gel packs that are usually kept in the freezer until needed. These are one of the simplest, time-tested remedies for managing pain and swelling. It works by reducing blood flow to a particular area, which can significantly reduce inflammation and swelling that causes pain, especially around a joint or a tendon. It can temporarily reduce nerve activity, which can also relieve pain.
Cold pain therapy plays a major role in managing the pain caused due to musculoskeletal disorder or sports related injuries. Thus, a rise in the number of sports-related injuries is anticipated to fuel the demand for cold pain therapy products that boost the growth of the cold pain therapy market size. For instance, according to data published by the National Safety Council in 2022 following a record low number of sports and recreational injuries reported in 2020, injuries increased 20% in 2021 and now have increased another 12% in 2022. In 2022, 3.6 million people were treated in emergency departments for injuries involving sports and recreational equipment. The activities most frequently associated with injuries are exercise, cycling, and basketball. Thus, the rise in the number of sports injuries is expected to cintribute significantly in the cold pain therapy market growth.
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Cold Pain Therapy OTC Products market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Romsons Group
Hisamitsu Pharmaceutical Co.,Inc
Sanofi
ThermoTek Inc
3M Company
Bruder Healthcare Company LLC
Beiersdorf AG
Össur
Medline Industries
LP
Cardinal Health Inc.
Segment by Type
Creams
Gels
Patches
Others
Segment by Application
Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the Cold Pain Therapy OTC Products study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Introduction to Cold Pain Therapy OTC Products: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Cold Pain Therapy OTC Products Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Creams
1.2.3 Gels
1.2.4 Patches
1.2.5 Others
1.3 Market Segmentation by Application
1.3.1 Global Cold Pain Therapy OTC Products Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospitals Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Cold Pain Therapy OTC Products Revenue Estimates and Forecasts 2020-2031
2.2 Global Cold Pain Therapy OTC Products Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Cold Pain Therapy OTC Products Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Cold Pain Therapy OTC Products Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Creams Market Size by Players
3.3.2 Gels Market Size by Players
3.3.3 Patches Market Size by Players
3.3.4 Others Market Size by Players
3.4 Global Cold Pain Therapy OTC Products Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Cold Pain Therapy OTC Products Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Cold Pain Therapy OTC Products Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Cold Pain Therapy OTC Products Market Size by Type (2020-2031)
6.4 North America Cold Pain Therapy OTC Products Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Cold Pain Therapy OTC Products Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Cold Pain Therapy OTC Products Market Size by Type (2020-2031)
7.4 Europe Cold Pain Therapy OTC Products Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Cold Pain Therapy OTC Products Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Cold Pain Therapy OTC Products Market Size by Type (2020-2031)
8.4 Asia-Pacific Cold Pain Therapy OTC Products Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Cold Pain Therapy OTC Products Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Cold Pain Therapy OTC Products Market Size by Type (2020-2031)
9.4 Central and South America Cold Pain Therapy OTC Products Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Cold Pain Therapy OTC Products Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Cold Pain Therapy OTC Products Market Size by Type (2020-2031)
10.4 Middle East and Africa Cold Pain Therapy OTC Products Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Cold Pain Therapy OTC Products Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Romsons Group
11.1.1 Romsons Group Corporation Information
11.1.2 Romsons Group Business Overview
11.1.3 Romsons Group Cold Pain Therapy OTC Products Product Features and Attributes
11.1.4 Romsons Group Cold Pain Therapy OTC Products Revenue and Gross Margin (2020-2025)
11.1.5 Romsons Group Cold Pain Therapy OTC Products Revenue by Product in 2024
11.1.6 Romsons Group Cold Pain Therapy OTC Products Revenue by Application in 2024
11.1.7 Romsons Group Cold Pain Therapy OTC Products Revenue by Geographic Area in 2024
11.1.8 Romsons Group Cold Pain Therapy OTC Products SWOT Analysis
11.1.9 Romsons Group Recent Developments
11.2 Hisamitsu Pharmaceutical Co.,Inc
11.2.1 Hisamitsu Pharmaceutical Co.,Inc Corporation Information
11.2.2 Hisamitsu Pharmaceutical Co.,Inc Business Overview
11.2.3 Hisamitsu Pharmaceutical Co.,Inc Cold Pain Therapy OTC Products Product Features and Attributes
11.2.4 Hisamitsu Pharmaceutical Co.,Inc Cold Pain Therapy OTC Products Revenue and Gross Margin (2020-2025)
11.2.5 Hisamitsu Pharmaceutical Co.,Inc Cold Pain Therapy OTC Products Revenue by Product in 2024
11.2.6 Hisamitsu Pharmaceutical Co.,Inc Cold Pain Therapy OTC Products Revenue by Application in 2024
11.2.7 Hisamitsu Pharmaceutical Co.,Inc Cold Pain Therapy OTC Products Revenue by Geographic Area in 2024
11.2.8 Hisamitsu Pharmaceutical Co.,Inc Cold Pain Therapy OTC Products SWOT Analysis
11.2.9 Hisamitsu Pharmaceutical Co.,Inc Recent Developments
11.3 Sanofi
11.3.1 Sanofi Corporation Information
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Cold Pain Therapy OTC Products Product Features and Attributes
11.3.4 Sanofi Cold Pain Therapy OTC Products Revenue and Gross Margin (2020-2025)
11.3.5 Sanofi Cold Pain Therapy OTC Products Revenue by Product in 2024
11.3.6 Sanofi Cold Pain Therapy OTC Products Revenue by Application in 2024
11.3.7 Sanofi Cold Pain Therapy OTC Products Revenue by Geographic Area in 2024
11.3.8 Sanofi Cold Pain Therapy OTC Products SWOT Analysis
11.3.9 Sanofi Recent Developments
11.4 ThermoTek Inc
11.4.1 ThermoTek Inc Corporation Information
11.4.2 ThermoTek Inc Business Overview
11.4.3 ThermoTek Inc Cold Pain Therapy OTC Products Product Features and Attributes
11.4.4 ThermoTek Inc Cold Pain Therapy OTC Products Revenue and Gross Margin (2020-2025)
11.4.5 ThermoTek Inc Cold Pain Therapy OTC Products Revenue by Product in 2024
11.4.6 ThermoTek Inc Cold Pain Therapy OTC Products Revenue by Application in 2024
11.4.7 ThermoTek Inc Cold Pain Therapy OTC Products Revenue by Geographic Area in 2024
11.4.8 ThermoTek Inc Cold Pain Therapy OTC Products SWOT Analysis
11.4.9 ThermoTek Inc Recent Developments
11.5 3M Company
11.5.1 3M Company Corporation Information
11.5.2 3M Company Business Overview
11.5.3 3M Company Cold Pain Therapy OTC Products Product Features and Attributes
11.5.4 3M Company Cold Pain Therapy OTC Products Revenue and Gross Margin (2020-2025)
11.5.5 3M Company Cold Pain Therapy OTC Products Revenue by Product in 2024
11.5.6 3M Company Cold Pain Therapy OTC Products Revenue by Application in 2024
11.5.7 3M Company Cold Pain Therapy OTC Products Revenue by Geographic Area in 2024
11.5.8 3M Company Cold Pain Therapy OTC Products SWOT Analysis
11.5.9 3M Company Recent Developments
11.6 Bruder Healthcare Company LLC
11.6.1 Bruder Healthcare Company LLC Corporation Information
11.6.2 Bruder Healthcare Company LLC Business Overview
11.6.3 Bruder Healthcare Company LLC Cold Pain Therapy OTC Products Product Features and Attributes
11.6.4 Bruder Healthcare Company LLC Cold Pain Therapy OTC Products Revenue and Gross Margin (2020-2025)
11.6.5 Bruder Healthcare Company LLC Recent Developments
11.7 Beiersdorf AG
11.7.1 Beiersdorf AG Corporation Information
11.7.2 Beiersdorf AG Business Overview
11.7.3 Beiersdorf AG Cold Pain Therapy OTC Products Product Features and Attributes
11.7.4 Beiersdorf AG Cold Pain Therapy OTC Products Revenue and Gross Margin (2020-2025)
11.7.5 Beiersdorf AG Recent Developments
11.8 Össur
11.8.1 Össur Corporation Information
11.8.2 Össur Business Overview
11.8.3 Össur Cold Pain Therapy OTC Products Product Features and Attributes
11.8.4 Össur Cold Pain Therapy OTC Products Revenue and Gross Margin (2020-2025)
11.8.5 Össur Recent Developments
11.9 Medline Industries
11.9.1 Medline Industries Corporation Information
11.9.2 Medline Industries Business Overview
11.9.3 Medline Industries Cold Pain Therapy OTC Products Product Features and Attributes
11.9.4 Medline Industries Cold Pain Therapy OTC Products Revenue and Gross Margin (2020-2025)
11.9.5 Medline Industries Recent Developments
11.10 LP
11.10.1 LP Corporation Information
11.10.2 LP Business Overview
11.10.3 LP Cold Pain Therapy OTC Products Product Features and Attributes
11.10.4 LP Cold Pain Therapy OTC Products Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Cardinal Health Inc.
11.11.1 Cardinal Health Inc. Corporation Information
11.11.2 Cardinal Health Inc. Business Overview
11.11.3 Cardinal Health Inc. Cold Pain Therapy OTC Products Product Features and Attributes
11.11.4 Cardinal Health Inc. Cold Pain Therapy OTC Products Revenue and Gross Margin (2020-2025)
11.11.5 Cardinal Health Inc. Recent Developments
12 Cold Pain Therapy OTC ProductsIndustry Chain Analysis
12.1 Cold Pain Therapy OTC Products Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Cold Pain Therapy OTC Products Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Cold Pain Therapy OTC Products Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Cold Pain Therapy OTC Products Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Cold Pain Therapy OTC Products Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Cold Pain Therapy OTC Products Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Cold Pain Therapy OTC Products Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Cold Pain Therapy OTC Products Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Cold Pain Therapy OTC Products Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Cold Pain Therapy OTC Products Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Cold Pain Therapy OTC Products by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cold Pain Therapy OTC Products as of 2024)
Table 11. Global Cold Pain Therapy OTC Products Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Cold Pain Therapy OTC Products Companies Headquarters
Table 13. Global Cold Pain Therapy OTC Products Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Cold Pain Therapy OTC Products Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Cold Pain Therapy OTC Products Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Cold Pain Therapy OTC Products Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Cold Pain Therapy OTC Products Revenue by Application (2026-2031) & (US$ Million)
Table 21. Cold Pain Therapy OTC Products High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Cold Pain Therapy OTC Products Growth Accelerators and Market Barriers
Table 25. North America Cold Pain Therapy OTC Products Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Cold Pain Therapy OTC Products Growth Accelerators and Market Barriers
Table 27. Europe Cold Pain Therapy OTC Products Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Cold Pain Therapy OTC Products Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Cold Pain Therapy OTC Products Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Cold Pain Therapy OTC Products Investment Opportunities and Key Challenges
Table 31. Central and South America Cold Pain Therapy OTC Products Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Cold Pain Therapy OTC Products Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Cold Pain Therapy OTC Products Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Romsons Group Corporation Information
Table 35. Romsons Group Description and Major Businesses
Table 36. Romsons Group Product Features and Attributes
Table 37. Romsons Group Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Romsons Group Revenue Proportion by Product in 2024
Table 39. Romsons Group Revenue Proportion by Application in 2024
Table 40. Romsons Group Revenue Proportion by Geographic Area in 2024
Table 41. Romsons Group Cold Pain Therapy OTC Products SWOT Analysis
Table 42. Romsons Group Recent Developments
Table 43. Hisamitsu Pharmaceutical Co.,Inc Corporation Information
Table 44. Hisamitsu Pharmaceutical Co.,Inc Description and Major Businesses
Table 45. Hisamitsu Pharmaceutical Co.,Inc Product Features and Attributes
Table 46. Hisamitsu Pharmaceutical Co.,Inc Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Hisamitsu Pharmaceutical Co.,Inc Revenue Proportion by Product in 2024
Table 48. Hisamitsu Pharmaceutical Co.,Inc Revenue Proportion by Application in 2024
Table 49. Hisamitsu Pharmaceutical Co.,Inc Revenue Proportion by Geographic Area in 2024
Table 50. Hisamitsu Pharmaceutical Co.,Inc Cold Pain Therapy OTC Products SWOT Analysis
Table 51. Hisamitsu Pharmaceutical Co.,Inc Recent Developments
Table 52. Sanofi Corporation Information
Table 53. Sanofi Description and Major Businesses
Table 54. Sanofi Product Features and Attributes
Table 55. Sanofi Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Sanofi Revenue Proportion by Product in 2024
Table 57. Sanofi Revenue Proportion by Application in 2024
Table 58. Sanofi Revenue Proportion by Geographic Area in 2024
Table 59. Sanofi Cold Pain Therapy OTC Products SWOT Analysis
Table 60. Sanofi Recent Developments
Table 61. ThermoTek Inc Corporation Information
Table 62. ThermoTek Inc Description and Major Businesses
Table 63. ThermoTek Inc Product Features and Attributes
Table 64. ThermoTek Inc Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. ThermoTek Inc Revenue Proportion by Product in 2024
Table 66. ThermoTek Inc Revenue Proportion by Application in 2024
Table 67. ThermoTek Inc Revenue Proportion by Geographic Area in 2024
Table 68. ThermoTek Inc Cold Pain Therapy OTC Products SWOT Analysis
Table 69. ThermoTek Inc Recent Developments
Table 70. 3M Company Corporation Information
Table 71. 3M Company Description and Major Businesses
Table 72. 3M Company Product Features and Attributes
Table 73. 3M Company Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. 3M Company Revenue Proportion by Product in 2024
Table 75. 3M Company Revenue Proportion by Application in 2024
Table 76. 3M Company Revenue Proportion by Geographic Area in 2024
Table 77. 3M Company Cold Pain Therapy OTC Products SWOT Analysis
Table 78. 3M Company Recent Developments
Table 79. Bruder Healthcare Company LLC Corporation Information
Table 80. Bruder Healthcare Company LLC Description and Major Businesses
Table 81. Bruder Healthcare Company LLC Product Features and Attributes
Table 82. Bruder Healthcare Company LLC Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Bruder Healthcare Company LLC Recent Developments
Table 84. Beiersdorf AG Corporation Information
Table 85. Beiersdorf AG Description and Major Businesses
Table 86. Beiersdorf AG Product Features and Attributes
Table 87. Beiersdorf AG Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Beiersdorf AG Recent Developments
Table 89. Össur Corporation Information
Table 90. Össur Description and Major Businesses
Table 91. Össur Product Features and Attributes
Table 92. Össur Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Össur Recent Developments
Table 94. Medline Industries Corporation Information
Table 95. Medline Industries Description and Major Businesses
Table 96. Medline Industries Product Features and Attributes
Table 97. Medline Industries Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Medline Industries Recent Developments
Table 99. LP Corporation Information
Table 100. LP Description and Major Businesses
Table 101. LP Product Features and Attributes
Table 102. LP Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. LP Recent Developments
Table 104. Cardinal Health Inc. Corporation Information
Table 105. Cardinal Health Inc. Description and Major Businesses
Table 106. Cardinal Health Inc. Product Features and Attributes
Table 107. Cardinal Health Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Cardinal Health Inc. Recent Developments
Table 109. Raw Materials Key Suppliers
Table 110. Distributors List
Table 111. Market Trends and Market Evolution
Table 112. Market Drivers and Opportunities
Table 113. Market Challenges, Risks, and Restraints
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Cold Pain Therapy OTC Products Product Picture
Figure 2. Global Cold Pain Therapy OTC Products Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Creams Product Picture
Figure 4. Gels Product Picture
Figure 5. Patches Product Picture
Figure 6. Others Product Picture
Figure 7. Global Cold Pain Therapy OTC Products Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Hospitals Pharmacies
Figure 9. Retail Pharmacies
Figure 10. Online Pharmacies
Figure 11. Cold Pain Therapy OTC Products Report Years Considered
Figure 12. Global Cold Pain Therapy OTC Products Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Cold Pain Therapy OTC Products Revenue (2020-2031) & (US$ Million)
Figure 14. Global Cold Pain Therapy OTC Products Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Cold Pain Therapy OTC Products Revenue Market Share by Region (2020-2031)
Figure 16. Global Cold Pain Therapy OTC Products Revenue Market Share Ranking (2024)
Figure 17. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 18. Creams Revenue Market Share by Player in 2024
Figure 19. Gels Revenue Market Share by Player in 2024
Figure 20. Patches Revenue Market Share by Player in 2024
Figure 21. Others Revenue Market Share by Player in 2024
Figure 22. Global Cold Pain Therapy OTC Products Revenue Market Share by Type (2020-2031)
Figure 23. Global Cold Pain Therapy OTC Products Revenue Market Share by Application (2020-2031)
Figure 24. North America Cold Pain Therapy OTC Products Revenue YoY (2020-2031) & (US$ Million)
Figure 25. North America Top 5 Players Cold Pain Therapy OTC Products Revenue (US$ Million) in 2024
Figure 26. North America Cold Pain Therapy OTC Products Revenue (US$ Million) by Type (2020 - 2031)
Figure 27. North America Cold Pain Therapy OTC Products Revenue (US$ Million) by Application (2020-2031)
Figure 28. US Cold Pain Therapy OTC Products Revenue (2020-2031) & (US$ Million)
Figure 29. Canada Cold Pain Therapy OTC Products Revenue (2020-2031) & (US$ Million)
Figure 30. Mexico Cold Pain Therapy OTC Products Revenue (2020-2031) & (US$ Million)
Figure 31. Europe Cold Pain Therapy OTC Products Revenue YoY (2020-2031) & (US$ Million)
Figure 32. Europe Top 5 Players Cold Pain Therapy OTC Products Revenue (US$ Million) in 2024
Figure 33. Europe Cold Pain Therapy OTC Products Revenue (US$ Million) by Type (2020-2031)
Figure 34. Europe Cold Pain Therapy OTC Products Revenue (US$ Million) by Application (2020-2031)
Figure 35. Germany Cold Pain Therapy OTC Products Revenue (2020-2031) & (US$ Million)
Figure 36. France Cold Pain Therapy OTC Products Revenue (2020-2031) & (US$ Million)
Figure 37. U.K. Cold Pain Therapy OTC Products Revenue (2020-2031) & (US$ Million)
Figure 38. Italy Cold Pain Therapy OTC Products Revenue (2020-2031) & (US$ Million)
Figure 39. Russia Cold Pain Therapy OTC Products Revenue (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific Cold Pain Therapy OTC Products Revenue YoY (2020-2031) & (US$ Million)
Figure 41. Asia-Pacific Top 8 Players Cold Pain Therapy OTC Products Revenue (US$ Million) in 2024
Figure 42. Asia-Pacific Cold Pain Therapy OTC Products Revenue (US$ Million) by Type (2020-2031)
Figure 43. Asia-Pacific Cold Pain Therapy OTC Products Revenue (US$ Million) by Application (2020-2031)
Figure 44. Indonesia Cold Pain Therapy OTC Products Revenue (2020-2031) & (US$ Million)
Figure 45. Japan Cold Pain Therapy OTC Products Revenue (2020-2031) & (US$ Million)
Figure 46. South Korea Cold Pain Therapy OTC Products Revenue (2020-2031) & (US$ Million)
Figure 47. Australia Cold Pain Therapy OTC Products Revenue (2020-2031) & (US$ Million)
Figure 48. India Cold Pain Therapy OTC Products Revenue (2020-2031) & (US$ Million)
Figure 49. Indonesia Cold Pain Therapy OTC Products Revenue (2020-2031) & (US$ Million)
Figure 50. Vietnam Cold Pain Therapy OTC Products Revenue (2020-2031) & (US$ Million)
Figure 51. Malaysia Cold Pain Therapy OTC Products Revenue (2020-2031) & (US$ Million)
Figure 52. Philippines Cold Pain Therapy OTC Products Revenue (2020-2031) & (US$ Million)
Figure 53. Singapore Cold Pain Therapy OTC Products Revenue (2020-2031) & (US$ Million)
Figure 54. Central and South America Cold Pain Therapy OTC Products Revenue YoY (2020-2031) & (US$ Million)
Figure 55. Central and South America Top 5 Players Cold Pain Therapy OTC Products Revenue (US$ Million) in 2024
Figure 56. Central and South America Cold Pain Therapy OTC Products Revenue (US$ Million) by Type (2020-2031)
Figure 57. Central and South America Cold Pain Therapy OTC Products Revenue (US$ Million) by Application (2020-2031)
Figure 58. Brazil Cold Pain Therapy OTC Products Revenue (2020-2025) & (US$ Million)
Figure 59. Argentina Cold Pain Therapy OTC Products Revenue (2020-2025) & (US$ Million)
Figure 60. Middle East and Africa Cold Pain Therapy OTC Products Revenue YoY (2020-2031) & (US$ Million)
Figure 61. Middle East and Africa Top 5 Players Cold Pain Therapy OTC Products Revenue (US$ Million) in 2024
Figure 62. South America Cold Pain Therapy OTC Products Revenue (US$ Million) by Type (2020-2031)
Figure 63. Middle East and Africa Cold Pain Therapy OTC Products Revenue (US$ Million) by Application (2020-2031)
Figure 64. GCC Countries Cold Pain Therapy OTC Products Revenue (2020-2025) & (US$ Million)
Figure 65. Israel Cold Pain Therapy OTC Products Revenue (2020-2025) & (US$ Million)
Figure 66. Egypt Cold Pain Therapy OTC Products Revenue (2020-2025) & (US$ Million)
Figure 67. South Africa Cold Pain Therapy OTC Products Revenue (2020-2025) & (US$ Million)
Figure 68. Cold Pain Therapy OTC Products Industry Chain Mapping
Figure 69. Channels of Distribution (Direct Vs Distribution)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
